2YoshinoM,Kunlmann MK,Kotanko P,et al.International differencec in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality[J].J AmSoc Nephrol,2006,17:3510.
3O'Riordan E,Foley RN.Efects of anaemia on cardiovascular status[J].Nephrol Dial Transplant,2000,15(Suppl 3):19.
二级参考文献9
1Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method[J ]. Circulation, 1977, 55: 613.
2Wizenmann V, Schafer AD, Kramer W, et al. Follow up of cardiac chang induced by anemia compension in nomotensive hemodialysis patients with left ventricular hypertrophy[J]. Nephron, 1993, 64(2) :202.
3Robert NF, Patrick SP, Mark JS. Cardiovascular disease in chronic renal disease[J]. Am J Kidney Dis, 1998, 32 (Suppl 3): 112.
4Parfrey PS, Hamett JD, Griffiths SM, et al. The clinic course of left ventricular hypertropy in dialysis patients[J]. Nephron, 1990, 55:114.
5Dahan M, Sichan P, Viron B, et al. Relationship between left ventricular hypertropy: myocardial contractility; and load conditions in hemodialysis patients; and echocardio graphic study[J]. Am J Kidney Dis, 1997, 30:780.
6Hamett JD, Murphy B, Collingwood P, et al. The reliability and validity of echocardiographic measurement of left ventricular mass in hemodialysis patients [ J ]. Nephron, 1993, 65:212.
7Greave, SC, Gamble GD, Collins JF, et al. Determination of left ventricular hypertrophy and systolic dysfunction in chronic renal failure[J]. Am J Kidney Dis, 1994, 24(5): 768.
8Washio M, Okuda S, Mizoue T, et al. Risk factors for left ventricular hypertrophy in chronic hemodiakysis patients[J]. Clin Nephrol, 1997, 47(6) :362.
9Kidus-diefed. Schliiten Hans Michael piper"Cardiovascular action of parathyroid hormone and paraghyroid hormone related peptide" [J ]. Cardiovasc Res, 1998, 37: 54.
